Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq
Insider Sale
+$2,868
-2.73%
Shares
Shares Volume: 5,032 Shares
Average Share Price: $0.57
INSIDER
Litton Mark James
President and CEO (Director)
reported on Sep 5 2024
traded on Sep 3 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 179,054 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $10,306.88 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 2 / 10 |
| P/S VALUE RATIO | 21.01 |
| AVERAGE SALE VALUE | $7,304.58 |
| COMPANY PREVIOUS TRADES |